Isolated antigenic oncogene peptide fragments and uses

作者: Ichiro Yoshino , Timothy J. Eberlein , George E. Peoples , Peter Goedegebuure

DOI:

关键词:

摘要: An isolated antigenic peptide fragment that is an oncogene protein disclosed. The of the invention a either 9 or 10 amino acid residues in length includes at least leucine residue C- terminus (i.e., position 10). capable binding HLA-A2 cleft and stimulating proliferation one tumor-specific cytotoxic T-lymphocyte. Preferred peptides further include isoleucine 2 valine 6. most preferred can stimulate T-lymphocytes obtainable from peripheral blood lymphocytes, ovarian tumors, breast gastric non-small cell lung pancreatic colon gliomas, bladder endometrial tumors neuroblastomas. mutant defined by SEQ ID NO.:2 its functional equivalents. Isolated recognizing invention, particularly HER2/neu are These lymphocytes especially useful for killing other cells which present on their surfaces invention. In particular, tumor cells, non-small-cell cells. A method described. This obtaining tissue contacting with under conditions sufficient to proliferate. Therapeutically effective compositions containing also

参考文章(18)
W E Biddison, J E Coligan, H J Zweerink, M A Bednarek, U Utz, L K Hull, K C Parker, B Cunningham, Sequence motifs important for peptide binding to the human MHC class I molecule, HLA-A2. Journal of Immunology. ,vol. 149, pp. 3580- 3587 ,(1992)
I Yoshino, T J Eberlein, A S Parikh, G E Peoples, P S Goedegebuure, H K Lyerly, A F Gazdar, J M DiMaio, HER2/neu-derived peptides are shared antigens among human non-small cell lung cancer and ovarian cancer. Cancer Research. ,vol. 54, pp. 3387- 3390 ,(1994)
William L. McGuire, Dennis J. Slamon, Determination of status in neoplastic disease ,(1986)
T. J. Eberlein, J. V. R. Andrews, G. E. Peoples, P. S. Goedegebuure, D. D. Schoof, HLA-A2 Presents Shared Tumor-Associated Antigens Derived from Endogenous Proteins in Ovarian Cancer' Journal of Immunology. ,vol. 151, pp. 5481- 5491 ,(1993)
H J Zweerink, M A Bednarek, G Porter, S Tamhankar, M C Gammon, S Y Sauma, A R Williamson, The minimum peptide epitope from the influenza virus matrix protein. Extra and intracellular loading of HLA-A2. Journal of Immunology. ,vol. 147, pp. 4047- 4053 ,(1991)
Kirsten Falk, Olaf Rötzschke, Stefan Stevanovié, Günther Jung, Hans-Georg Rammensee, Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature. ,vol. 351, pp. 290- 296 ,(1991) , 10.1038/351290A0
P. Di Fiore, J. Pierce, M. Kraus, O Segatto, C. King, S. Aaronson, erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells Science. ,vol. 237, pp. 178- 182 ,(1987) , 10.1126/SCIENCE.2885917
Hans W. Nijman, Jos G. A. Houbiers, Sjoerd H. van der Burg, Michel P. M. Vierboom, Peter Kenemans, W. Martin Kast, Cornelis J. M. Melief, Characterization of cytotoxic T lymphocyte epitopes of a self-protein, p53, and a non-self-protein, influenza matrix: relationship between major histocompatibility complex peptide binding affinity and immune responsiveness to peptides. Journal of Immunotherapy. ,vol. 14, pp. 121- 126 ,(1993) , 10.1097/00002371-199308000-00007
Samir Y. Sauma, Maureen C. Gammon, Maria A. Bednarek, Barry Cunningham, William E. Biddison, Jeffrey D. Hermes, Gene Porter, Snehal Tamhankar, Julio C. Hawkins, Bruce L. Bush, Alan R. Williamson, Hans J. Zweerink, Recognition by HLA-A2-restricted cytotoxic T lymphocytes of endogenously generated and exogenously provided synthetic peptide analogues of the influenza a virus matrix protein Human Immunology. ,vol. 37, pp. 252- 258 ,(1993) , 10.1016/0198-8859(93)90508-X
Constantin G. Ioannides, Bryan Fisk, Dominic Fan, William E. Biddison, J.Taylor Wharton, Catherine A. O'brian, Cytotoxic T Cells Isolated from Ovarian Malignant Ascites Recognize a Peptide Derived from the HER-2/neu Proto-oncogene Cellular Immunology. ,vol. 151, pp. 225- 234 ,(1993) , 10.1006/CIMM.1993.1233